LinusBio is a biotechnology company developing a precision diagnostic platform that analyzes the exposome using advanced hair-based molecular profiling.

 

LinusBio technology combines mass spectrometry, robotics, and AI to detect time-mapped biomarkers for conditions such as autism, ALS, and other complex disorders. With a noninvasive “hair-strand sequencing” approach, LinusBio enables early detection, better clinical insights, and improved patient care through scalable and highly precise molecular diagnostics.